期刊名称：RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.
Indexed in:
Science Citation Index Expanded, Index to Scientific Reviews®, Journal Citation Reports/Science Edition, MEDLINE/PubMed, EMBASE, Scopus, Chemical Abstracts, Cambridge Scientific Abstracts (CSA), METADEX, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory
You may also be interested in:
SUBSCRIPTION BASED JOURNALS
Recent Patents on Cardiovascular Drug Discovery
Recent Patents on CNS Drug Discovery
Recent Patents on Anti-Infective Drug Discovery
Current Pharmaceutical Design
Anti-Cancer Agents in Medicinal Chemistry
Current Cancer Drug Targets
Current Cancer Therapy Reviews
BENTHAM OPEN JOURNALS
Molecular Mechanism and Morphology in Cancer
A Casebook on Pediatric Diseases
Frontiers in Natural Product Chemistry
Instructions to Authors
Instructions for Authors
Regular manuscripts may be submitted directly to the Editorial Office by e-mail to patents@bentham.org or pra@bentham.org.
ONLINE MANUSCRIPT SUBMISSION: An online submission and tracking service via internet facilitates a speedy and cost-effective submission of manuscripts. The full manuscript should be submitted online via Bentham's Content Management System (CMS) at www.bentham-editorial.org (View Instructions).
Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Cover Letter along with the manuscript, on behalf of all the co-authors (if any) to confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. The figures from patent documents are freely available on the databases and may not require any permission unless stated otherwise.
For all online submissions, please provide soft copies of all the materials (main text in MS Word or Tex/LaTeX), figures / illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures / illustrations / tables / chemical structures etc.
It is imperative that before submission, the author(s) should carefully proofread the files for special characters, mathematical symbols, Greek letters, equations, tables, references and images to ensure that they appear in proper format.
References, figures, tables, chemical structures, etc. should be referred to in the text at the appropriate places where they have been first discussed. Figure legends / captions should also be provided.
A successful electronic submission of the manuscript will be confirmed by a system-generated email acknowledgement to the principal/corresponding author immediately. Any queries therein should be addressed at patents bentham.org and copied to prabentham.org.
MANUSCRIPTS PUBLISHED: The journal accepts mini- and full-length review articles written in English. Single Topic / Thematic Issues by invited Guest Editors (GE) are also considered for publication.
Thematic Issues: The Guest Editor (GE) will invite eminent authors from different countries and different institutions to contribute articles. As per policy, the contributors and authors for the thematic issue should not be from the same institute and with at least half of the contributions from different countries e.g., USA, UK, France, Canada, Germany, etc. At the time of submission, the Guest Editor (GE) will have to provide a brief description of the proposed topic outlining the aims & scope of the issue, the list of titles with author names and affiliations, and keywords on recent patents to be discussed in the proposed title. The Guest Editor (GE) and the authors will also provide specific keywords other than already in the titles for the compilation of patent selection.
The Thematic Issue, will need to have about 100-120 printed pages from contributions by 6 to 8 authors. Alternatively, a Mini-Thematic Issue can also be considered whereby half the required number of pages and contributors (i.e. 3 to 4 authors) would be required.
The Guest Editor (GE) is responsible to review the complete issue and forward the finalized manuscripts along with an Editorial to the journal's Editor-in-Chief for approval, within the given time frame.
Patent Selections: A separate section of important and recent patents on anti-cancer drug discovery is also included in the journal. The patents annotated in this section are relevant to the articles published in this journal issue, categorized by therapeutic areas/targets and therapeutic agents related to anti-cancer drug discovery.
MANUSCRIPT PREPARATION: The manuscript should be written in English in a clear, direct and active style. All pages must be numbered sequentially, facilitating in the reviewing and editing of the manuscript. For further convenience, the customer support team available at Bentham Publishing Services (www.benthampublishingservices.com) can provide assistance to authors for the preparation of manuscripts.
MANUSCRIPT LENGTH: Page lengths can vary for mini-reviews of up to 12 journal pages and for longer reviews up to 30 journal pages. A printed journal page is ca. 900 words (excluding diagrams and figures). There is no restriction on the number of patents, figures or tables in the manuscript.
MANUSCRIPT SECTIONS FOR PAPERS:
Manuscripts for review articles submitted to the journal may be divided into the following sections:
Cover Letter: It is mandatory to submit a signed covering letter along with the manuscript, by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. All inconsistencies in the text and in the reference section and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article should not contain any material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. The authors should acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copy right agreement. To download the cover-letter please visit: www.bentham.org/pra/Covering-Letter.doc
Title: The title of the article should be precise and brief and must not be more than 120 characters. Authors should avoid the use of non-standard abbreviations. The title must be written in title case except for articles, conjunctions and prepositions.
Short Running Title: Authors must provide a short running title of their manuscript.
Authors Names and Affiliations: The names of the authors should be provided according to previous citations or as the authors would want them to be published along with the institutional affiliations and current address, telephone, cell & fax numbers and the email address must be provided, with an asterisk in front of the name of the principal author. The corresponding author should also be designated and the full address, telephone, cell & fax numbers and the email address must be stated to receive correspondence and galley proofs.
Abstract: The abstract summarizing the essential features of the review article should not exceed 200 words and must include information regarding patents.
Keywords: Authors must provide 6 to 8 keywords in alphabetical order.
Text Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. The acknowledgements (if any) and the references section must then follow. The review article should mention any previous important, recent and old reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments along with relevant patents. The authors should avoid presenting material which has already been published in a previous review. The authors are advised to present and discuss their observations in brief. The manuscript style must be uniform throughout the text and 10pt Times New Roman fonts should be used. The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. per se, et al., in vitro, in vivo, in situ, etc.
Patent Review Coverage: Authors should review the most recent and important patents based on the topic covered. Coverage of novel bioactive compounds, analogs & targets, techniques and drug design in all areas of anti-cancer drug discovery should be emphasized, including the significance of reported patents.
Current & Future Developments: The review article should conclude with a short section called “Current & Future DevelopmentsThe author(s) will give their opinion on the current and future important developments on the topic discussed in their article.
Symbols and Units: Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of a manuscript for publication. To ensure that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format styling (Symbol font face) otherwise they will be lost during the conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These guidelines provide a set of recommendations comprising a list of items relevant to their specific research design.
Only ISO symbols, written in italic, should be used for the various parameters. All kinds of measurements should be reported only in International System of Units (SI). SI units should always be written in Roman and separated from the numerical value by a space (whatever the language).
A list of symbols and units should be provided if used extensively throughout the text.
List of Abbreviations: If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided.
Acknowledgements: Financial contributions to the work being reported should be clearly acknowledged. Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgement section.
This journal complies with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals www.icmje.org and the FDA's Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices www.fda.gov/oc/op/goodreprint.html.
Conflict of Interest: Any potential conflict of interest should be clearly acknowledged. No patents should be cited by authors that are in various stages of legal litigation.
References: References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. All references must be complete and accurate. Online citations should include the date of access. Journal titles should conform to the present Index Medicus abbreviations. It is necessary to list all authors if the total number of authors is 6 or less and for more than 6 authors use 6 authors and then et al. The reference numbers must be finalized and the bibliography must be fully formatted before submission.
References should be listed in the following Vancouver Style:
[1] Journal: Boehm M, Nabel EG. Angiotensin-converting enzyme 2 - A new cardiac regulator. N Engl J Med 2002; 347: 1795-7.
[2] Book: Crabtree RH. The Organometallic Chemistry of the Transition Metals. 3rd ed. Wiley & Sons: New York 2001.
[3] Book Chapter: Yeh DC, Rocco T. In: David EG, Armen HT, Ehrin JA, April WA, Eds. Integrative Cardiovascular Pharmacology. Philadelphia: Lippincott Williams & Wilkins 2005: 375-83.
[4] Conference Proceedings: Jakeman DL, Withers SGE. Carbohydrate Bioengineering: Interdisciplinary Approaches. Proceedings of the 4th Carbohydrate Bioengineering Meeting. Stockholm, Sweden, June 10-13, 2001.
[5] Meeting Abstract: Hoffman, BJ. Metabolism: Amino acid transporters as targets for therapeutic intervention. American Chemical Society - 228th National Meeting. Philadelphia, USA (2004).
[6] Website: National Library of Medicine. Specialized Information Services: Toxicology and Environmental Health. Available at: http://sis.nlm.nih.gov/Tox/ToxMain.html. (Accessed on: May 23, 2009).
[7] Thesis: Mackel H. Capturing the Spectra of Silicon Solar Cells. PhD Thesis, The Australian National University, Canberra, Australia, December 2004.
[8] Patent: As a service, the Publishers can provide each author a certain number of relevant patents to assist them in writing their article. All patent application references will be provided by the author and will be published as it is.
Patent Reference Style: All inventors��?names of the cited patents must be stated with the title, publication number and the year of publication e.g. Chesnut, J.D., Carrino, J., Leong, L., Madden, K., Gleeson, M.A.G., Fan, J., Brasch, M.A., Cheo, D., Hartley, J.L., Byrd, D.R.N., Temple, G.F. Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites. US7198924 (2007).
Editorial Board
Editorial Board
Editor-in-Chief:
Khurshid Zaman
Bentham Science Publishers Ltd.
Associate Editors:
Andrew P. Mazar
Department of Biochemistry
Northwestern University
Evanston, IL, USA
Patrick Legembre
Department of Biochemistry
Faculty of Pharmacy
University Rennes-1
Rennes, France
Regional Editors:
Vasso Apostolopoulos
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Centre for Immunology Immunology and Vaccine Laboratory
Prahran, Australia
Alfredo Budillon
Experimental Pharmacology Unit
Dept. Experimental Oncology
National Cancer Institute Fondazione "G. Pascale"
Napoli, Italy
Irena Kostova
Department of Chemistry
Faculty of Pharmacy
Medical University
Sofia, Bulgaria
Luca Munaron
Department of Animal and Human Biology
University of Torino
Torino, Italy
Hongbin Sun
Department of Medicinal Chemistry
Center for Drug Discovery
China Pharmaceutical University
Nanjing, China
Takuya Watanabe
Department of Internal Medicine and Gastroenterology
The Nippon Dental University
School of Life Dentistry
Niigata, Japan
| 
